Cvi Holdings, LLC Verona Pharma PLC Transaction History

Cvi Holdings, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$7.08 - $9.33 $1.26 Million - $1.66 Million	-178,273 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.51 - $8.11 $1.47 Million - $2.16 Million	-266,172 Reduced 59.89%	178,273 $1.25 Million
Q3 2020 Nov 16, 2020	BUY	$4.45 - $10.2 $1.98 Million - $4.53 Million	444,445 New	444,445 $2.77 Million

218

70.5M

1.4M

299K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $3.8B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.